Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy-Reference-Cited by-同舟云学术

Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy

Published:2024-05 Issue: Volume:74 Page:101085
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Zhou Qin,Tu Xinyi,Hou Xiaonan,Yu Jia,Zhao Fei,Huang Jinzhou,Kloeber Jake,Olson Anna,Gao Ming,Luo Kuntian,Zhu Shouhai,Wu Zheming,Zhang Yong,Sun Chenyu,Zeng Xiangyu,Schoolmeester Kenneth J.,Weroha John S.,Hu Xiwen,Jiang Yanxia,Wang Liewei,Mutter Robert W.,Lou Zhenkun

Funder

NICHD

Mayo Clinic

American Society for Radiation Oncology

National Institutes of Health

Mayo Foundation for Medical Education and Research

Publisher

Elsevier BV

Reference48 articles.

1. SYK allelic loss and the role of Syk-regulated genes in breast cancer survival;Blancato;PLoS One,2014

2. Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY);Boughey;Clin. Cancer Res,2021

3. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance;Bouwman;Nat. Rev. Cancer,2012

4. Playing the end game: DNA double-strand break repair pathway choice;Chapman;Mol. Cell,2012

5. Mechanisms of DNA damage, repair, and mutagenesis;Chatterjee;Environ. Mol. Mutagen,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of circadian clock-related immunological prognostic index and molecular subtypes in prostate cancer;Discover Oncology;2024-09-11

2. CYP1B1 Promotes PARPi-Resistance via Histone H1.4 Interaction and Increased Chromatin Accessibility in Ovarian Cancer;Drug Resistance Updates;2024-09